Document is current
Any future updates will be listed below
-
Authors
Tannu, Manasi
Hess, Connie N.
Gutierrez, J. Antonio
Lopes, Renato
Swaminathan, Rajesh V.
Altin, S. Elissa
Rao, Sunil V.
-
Funding
Funding for this research was provided by:
CPC Clinical Research
Amgen Foundation
Bristol-Myers Squibb
GlaxoSmithKline
Medtronic
Pfizer
Sanofi
AstraZeneca United States
Pharmaceuticals Bayer
Boehringer Ingelheim
Novo Nordisk Fonden
Daiichi-Sankyo
- License Information
-
More Information
Article History
Accepted: 18 April 2024
First Online: 14 May 2024
Compliance with Ethical Standards
:
: Dr. Rao reports no relationships with industry. Dr Tannu reports no conflicts. Dr. Hess reports receiving salary support from CPC Clinical Research; a member of the Executive Committee for EVOLVE-MI; and a grant from Amgen to CPC Clinical Research to fund the EVOLVE-MI trial. Dr. Lopes reports grants from Amgen, Bristol-Myers Squibb, GlaxoSmithKline, Medtronic, Pfizer, and Sanofi; consulting fees from AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, and Novo Nordisk; payment or honoraria from AstraZeneca, Daiichi Sankyo, Novo Nordisk, and Pfizer. The other authors declare that they have no conflict of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
